Azelis strengthens its pharmaceutical presence in India by expanding its partnership with Roquette
22 February 2022
Azelis is pleased to announce a new agreement with Roquette for the distribution of their pharmaceutical cellulose product range in India.
Highlights & rationale
- This collaboration expands Azelis India’s footprint in the pharmaceutical excipient market segment.
- This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.
- This agreement is consistent with Azelis’ commitment to grow organically with strategic partners and expand its presence in developing and emerging economies such as India.
Roquette is a global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. Roquette’s products, including its plant-based excipients, combined with Azelis’ dedicated application laboratories and formulation proficiency, will allow both companies to provide customers and partners with tailor-made, innovative solutions.
Through this collaboration, Azelis India is expanding its comprehensive product portfolio with the inclusion of Roquette’s Microcrystalline Cellulose (MCC) and Croscarmellose Sodium (CCS) products. The new agreement is effective immediately.
Azelis’ well-regarded reputation in the industry, strong customer intimacy, knowledgeable sales and technical teams and formulation expertise were the deciding factors for Roquette to enter into this distribution agreement. Azelis was appointed as Roquette’s distribution partner for the plant care market in Asia Pacific in 2020, and for Food & Health in China in 2021.
Oscar Manuel Cortes Gutierrez, Roquette Global Head of Pharma Distribution Management comments:
“Azelis has been our preferred partner for many years, and we are happy to continue this pharma relationship in India, expanding from the Middle East & Africa. We are confident in Azelis’ ability to deliver best-in-class services and solutions to our customers, who will now have access to a wider range of customizable solutions for various applications. The synergies arising from combining our ingredients with Azelis’ technical capabilities will lead to more opportunities and growth in the region.”
Aparna Khurana, Azelis India Managing Director, states:
“The addition of Roquette’s innovative and plant-based ingredients to our pharma product offering in India can only be to our customers’ benefit. By strengthening our lateral value chain, we will be able to offer a more complete and complementary pharma portfolio, becoming a one-stop-shop for customers to formulate solutions that meet consumers’ unique requirements. We will work to ensure the continued success of our collaboration, by leveraging our sales capabilities and market knowledge.”